122 related articles for article (PubMed ID: 7530843)
21. Infection of human brain cells by HIV-1: restricted virus production in chronically infected human glial cell lines.
Brack-Werner R; Kleinschmidt A; Ludvigsen A; Mellert W; Neumann M; Herrmann R; Khim MC; Burny A; Müller-Lantzsch N; Stavrou D
AIDS; 1992 Mar; 6(3):273-85. PubMed ID: 1373627
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of human immunodeficiency virus type 1 activity in vitro by oligonucleotides composed entirely of guanosine and thymidine.
Ojwang J; Elbaggari A; Marshall HB; Jayaraman K; McGrath MS; Rando RF
J Acquir Immune Defic Syndr (1988); 1994 Jun; 7(6):560-70. PubMed ID: 7513761
[TBL] [Abstract][Full Text] [Related]
23. Mechanism of the inhibitory effect of curdlan sulfate on HIV-1 infection in vitro.
Jagodzinski PP; Wiaderkiewicz R; Kurzawski G; Kloczewiak M; Nakashima H; Hyjek E; Yamamoto N; Uryu T; Kaneko Y; Posner MR
Virology; 1994 Aug; 202(2):735-45. PubMed ID: 7913276
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of human immunodeficiency virus activity by phosphorodithioate oligodeoxycytidine.
Marshall WS; Beaton G; Stein CA; Matsukura M; Caruthers MH
Proc Natl Acad Sci U S A; 1992 Jul; 89(14):6265-9. PubMed ID: 1378623
[TBL] [Abstract][Full Text] [Related]
25. CpG oligodeoxynucleotides block human immunodeficiency virus type 1 replication in human lymphoid tissue infected ex vivo.
Schlaepfer E; Audigé A; von Beust B; Manolova V; Weber M; Joller H; Bachmann MF; Kundig TM; Speck RF
J Virol; 2004 Nov; 78(22):12344-54. PubMed ID: 15507621
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of HIV-1 replication by cyclopentenone prostaglandins in acutely infected human cells. Evidence for a transcriptional block.
Rozera C; Carattoli A; De Marco A; Amici C; Giorgi C; Santoro MG
J Clin Invest; 1996 Apr; 97(8):1795-803. PubMed ID: 8621762
[TBL] [Abstract][Full Text] [Related]
27. Persistent infection of MT-4 cells by human immunodeficiency virus type 1 becomes increasingly likely with in vitro serial passage of wild-type but not nef mutant virus.
Nishino Y; Nakaya T; Fujinaga K; Kishi M; Azuma I; Ikuta K
J Gen Virol; 1994 Sep; 75 ( Pt 9)():2241-51. PubMed ID: 7521392
[TBL] [Abstract][Full Text] [Related]
28. Several CD4 domains can play a role in human immunodeficiency virus infection in cells.
Poulin L; Evans LA; Tang SB; Barboza A; Legg H; Littman DR; Levy JA
J Virol; 1991 Sep; 65(9):4893-901. PubMed ID: 1714523
[TBL] [Abstract][Full Text] [Related]
29. Differential human immunodeficiency virus expression in CD4+ cloned lymphocytes: from viral latency to replication.
Chapel A; Bensussan A; Vilmer E; Dormont D
J Virol; 1992 Jun; 66(6):3966-70. PubMed ID: 1374814
[TBL] [Abstract][Full Text] [Related]
30. Resistance of the human immunodeficiency virus to the inhibitory action of negatively charged albumins on virus binding to CD4.
Cabrera C; Witvrouw M; Gutiérrez A; Clotet B; Kuipers ME; Swart PJ; Meijer DK; Desmyter J; De Clercq E; Esté JA
AIDS Res Hum Retroviruses; 1999 Nov; 15(17):1535-43. PubMed ID: 10580404
[TBL] [Abstract][Full Text] [Related]
31. Cholesteryl-conjugated oligonucleotides: synthesis, properties, and activity as inhibitors of replication of human immunodeficiency virus in cell culture.
Letsinger RL; Zhang GR; Sun DK; Ikeuchi T; Sarin PS
Proc Natl Acad Sci U S A; 1989 Sep; 86(17):6553-6. PubMed ID: 2771942
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of gp120-CD4 interaction and human immunodeficiency virus type 1 infection in vitro by pyridoxal 5'-phosphate.
Guo L; Heinzinger NK; Stevenson M; Schopfer LM; Salhany JM
Antimicrob Agents Chemother; 1994 Oct; 38(10):2483-7. PubMed ID: 7530934
[TBL] [Abstract][Full Text] [Related]
33. Aurothiolates inhibit HIV-1 infectivity by gold(I) ligand exchange with a component of the virion surface.
Okada T; Patterson BK; Ye SQ; Gurney ME
Virology; 1993 Feb; 192(2):631-42. PubMed ID: 8421903
[TBL] [Abstract][Full Text] [Related]
34. Hairpin antisense oligonucleotides containing 2'-methoxynucleosides with base-pairing in the stem region at the 3'-end: penetration, localization, and Anti-HIV activity.
Kuwasaki T; Hosono K; Takai K; Ushijima K; Nakashima H; Saito T; Yamamoto N; Takaku H
Biochem Biophys Res Commun; 1996 Nov; 228(2):623-31. PubMed ID: 8920960
[TBL] [Abstract][Full Text] [Related]
35. The influence of cell culture and storage conditions on HIV-1 infectivity and fusogenic activity.
Ongrádi J; Ceccherini-Nelli L; Szilágyi JF; Specter S; Pistello M; Laird HM; Bendinelli M
Acta Microbiol Hung; 1992; 39(3-4):207-21. PubMed ID: 1285337
[TBL] [Abstract][Full Text] [Related]
36. Differential effects of a hydrophobic tripeptide on human immunodeficiency virus type 1 (HIV-1)-induced syncytium formation and viral infectivity.
Konopka K; Pretzer E; Düzgünes N
Biochem Biophys Res Commun; 1995 Mar; 208(1):75-81. PubMed ID: 7887968
[TBL] [Abstract][Full Text] [Related]
37. Suppression of human immunodeficiency virus replication by ascorbate in chronically and acutely infected cells.
Harakeh S; Jariwalla RJ; Pauling L
Proc Natl Acad Sci U S A; 1990 Sep; 87(18):7245-9. PubMed ID: 1698293
[TBL] [Abstract][Full Text] [Related]
38. Curdlan sulfate and HIV-1. I. In vitro inhibitory effects of curdlan sulfate on HIV-1 infection.
Aoki T; Kaneko Y; Stefanski MS; Nguyen T; Ting RC
AIDS Res Hum Retroviruses; 1991 Apr; 7(4):409-15. PubMed ID: 1676899
[TBL] [Abstract][Full Text] [Related]
39. Inactivation of the human immunodeficiency virus by hypericin: evidence for photochemical alterations of p24 and a block in uncoating.
Degar S; Prince AM; Pascual D; Lavie G; Levin B; Mazur Y; Lavie D; Ehrlich LS; Carter C; Meruelo D
AIDS Res Hum Retroviruses; 1992 Nov; 8(11):1929-36. PubMed ID: 1283309
[TBL] [Abstract][Full Text] [Related]
40. Enhancement of HIV-1 cytocidal effects in CD4+ lymphocytes by the AIDS-associated mycoplasma.
Lo SC; Tsai S; Benish JR; Shih JW; Wear DJ; Wong DM
Science; 1991 Mar; 251(4997):1074-6. PubMed ID: 1705362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
